U.S. Markets close in 3 hrs

If You Like EPS Growth Then Check Out Greatview Aseptic Packaging (HKG:468) Before It's Too Late

Simply Wall St

Want to participate in a short research study? Help shape the future of investing tools and you could win a $250 gift card!

For beginners, it can seem like a good idea (and an exciting prospect) to buy a company that tells a good story to investors, even if it completely lacks a track record of revenue and profit. But as Warren Buffett has mused, 'If you've been playing poker for half an hour and you still don't know who the patsy is, you're the patsy.' When they buy such story stocks, investors are all too often the patsy.

So if you're like me, you might be more interested in profitable, growing companies, like Greatview Aseptic Packaging (HKG:468). While that doesn't make the shares worth buying at any price, you can't deny that successful capitalism requires profit, eventually. Conversely, a loss-making company is yet to prove itself with profit, and eventually the sweet milk of external capital may run sour.

View our latest analysis for Greatview Aseptic Packaging

Greatview Aseptic Packaging's Earnings Per Share Are Growing.

If a company can keep growing earnings per share (EPS) long enough, its share price will eventually follow. Therefore, there are plenty of investors who like to buy shares in companies that are growing EPS. Greatview Aseptic Packaging managed to grow EPS by 4.6% per year, over three years. That might not be particularly high growth, but it does show that per-share earnings are moving steadily in the right direction.

Careful consideration of revenue growth and earnings before interest and taxation (EBIT) margins can help inform a view on the sustainability of the recent profit growth. While Greatview Aseptic Packaging did well to grow revenue over the last year, EBIT margins were dampened at the same time. So it seems the future my hold further growth, especially if EBIT margins can stabilize.

The chart below shows how the company's bottom and top lines have progressed over time. Click on the chart to see the exact numbers.

SEHK:468 Income Statement, June 20th 2019

While it's always good to see growing profits, you should always remember that a weak balance sheet could come back to bite. So check Greatview Aseptic Packaging's balance sheet strength, before getting too excited.

Are Greatview Aseptic Packaging Insiders Aligned With All Shareholders?

I like company leaders to have some skin in the game, so to speak, because it increases alignment of incentives between the people running the business, and its true owners. So it is good to see that Greatview Aseptic Packaging insiders have a significant amount of capital invested in the stock. Indeed, they hold CN¥359m worth of its stock. That shows significant buy-in, and may indicate conviction in the business strategy. Those holdings account for over 6.2% of the company; visible skin in the game.

Does Greatview Aseptic Packaging Deserve A Spot On Your Watchlist?

As I already mentioned, Greatview Aseptic Packaging is a growing business, which is what I like to see. Just as polish makes silverware pop, the high level of insider ownership enhances my enthusiasm for this growth. The combination sparks joy for me, so I'd consider keeping the company on a watchlist. While we've looked at the quality of the earnings, we haven't yet done any work to value the stock. So if you like to buy cheap, you may want to check if Greatview Aseptic Packaging is trading on a high P/E or a low P/E, relative to its industry.

Although Greatview Aseptic Packaging certainly looks good to me, I would like it more if insiders were buying up shares. If you like to see insider buying, too, then this free list of growing companies that insiders are buying, could be exactly what you're looking for.

Please note the insider transactions discussed in this article refer to reportable transactions in the relevant jurisdiction

We aim to bring you long-term focused research analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.

If you spot an error that warrants correction, please contact the editor at editorial-team@simplywallst.com. This article by Simply Wall St is general in nature. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Simply Wall St has no position in the stocks mentioned. Thank you for reading.